老年痴呆实验动物模型研制进展.ppt

上传人:sccc 文档编号:5666189 上传时间:2023-08-07 格式:PPT 页数:48 大小:29.93MB
返回 下载 相关 举报
老年痴呆实验动物模型研制进展.ppt_第1页
第1页 / 共48页
老年痴呆实验动物模型研制进展.ppt_第2页
第2页 / 共48页
老年痴呆实验动物模型研制进展.ppt_第3页
第3页 / 共48页
老年痴呆实验动物模型研制进展.ppt_第4页
第4页 / 共48页
老年痴呆实验动物模型研制进展.ppt_第5页
第5页 / 共48页
点击查看更多>>
资源描述

《老年痴呆实验动物模型研制进展.ppt》由会员分享,可在线阅读,更多相关《老年痴呆实验动物模型研制进展.ppt(48页珍藏版)》请在三一办公上搜索。

1、老年痴呆实验动物模型研制进展 Research Progress of Animal Models for Alzheimers Disease,张 斌(Bin Zhang)M.D.,Ph.D.,Center for Neurodegenerative Disease Research,School of Medicine University of PennsylvaniaPhiladelphia,PA USA,High,Median,Low,Millions,Year,美国 85岁以上的人口统计US Population Demographics 85 Years of Age or Ol

2、der:1950-2050,Average life span in USAMale:72.2 years oldFemales:79.10 years old,美国老年痴呆发病率AD Incidence In US,AD afflicts 4 million Americans 100,000 die/year.AD occurs in men and women of all ethnic groups and at all socioeconomic levels.The US Census Bureau predicts that AD will affect 14 million A

3、mericans by 2050.,美国老年痴呆病人数量(百万)AD Patients In USA,1980 2005 2050,老年痴呆神经病理Neuropathology of AD,神经元纤维缠结(N FT)Neurofibrillary TanglesTau protein(细胞内),老年斑(SP)Senile Plaques淀粉样蛋白-Amyloid(A)(细胞外),理想的老年痴呆实验动物模型标志 Idea AD Animal Models,老年痴呆病人老年痴呆动物模型_病理表现神经元纤维缠结 细胞内形成tau蛋白纤维老年斑 细胞外形成 淀粉样蛋白纤维生化特点 Tau蛋白超磷酸化

4、类似AD Ab,Tau蛋白降低溶解性类似AD行为改变 记忆力下降或丧失,行为测试显示 记忆力下降或丧失_实验动物模型重复性,do not reduce the gene expressing level实验动物模型实用性,drug screen,mechanism study,老年痴呆实验动物模型种类Types of AD Animal Models,基因种类:正常和变异的基因 Normal and mutant genes Tau 蛋白,Tau protein b淀粉样前蛋白APP Presenin1,2,PS1,2 载脂蛋白E,Apolipoprotein E(ApoE)酶 b secra

5、tase Cyclin dependent kinase5(CDK5)glycogen synthase kinase3(GSK3)动物种类:非脊椎动物模型 果蝇模型 Drosophila model 线虫模型 Nematode Caenorhabditis elegans model 脊椎动物模型 小鼠模型 mouse model 大鼠模型 rat model,Alzheimer-type neuropathology in transgenic mice overexpressing V717F b-amyloid precursor protein.Dora Games et al.,N

6、ature 373,523-527,Tau transgenic C.elegans.Kraemer et al.,PNAS,100:9982-9985,Tau transgenic drosophilaJackson et al.,Neuron 34:509-519,Gtz et al.,Molecular Psychiatry 9,664,老年痴呆实验动物模型种类(续)Types of AD Animal Models,基因数量 单基因模型 Single Tg model,Tau,APP,PS1 双基因模型 double Tg model,Tau+APP,APP+PS1 三基因模型 tri

7、ple Tg model,Tau+APP+PS1基因表达的细胞 神经元细胞 neuron 神经胶质细胞 Neuronal glial cell 少突胶质细胞 Oligodendrocyte 星形胶质细胞 Astrocyte,Tau and APP double Tg mice.Lowis et al.,Science 293:1487-1491,Makoto Higuchi,Bin Zhang,Mark S.Forman,Yasumasa Yoshiyama,John Q.Trojanowski,and Virginia M.-Y.Lee J.Neurosci.,25:9434,2005,Ma

8、rk S.Forman,Devika Lal,Bin Zhang,Deepa V.Dabir,Eric Swanson,Virginia M.-Y.Lee,and John Q.Trojanowski The Journal of Neuroscience,2005,25:3539,1.Prepare your DNA+promoter2.Transform fertilized eggsHarvest freshly fertilized eggs before the sperm head has become a pronucleus.Inject the male pronucleus

9、 with your DNA.When the pronuclei have fused to form the diploid zygote nucleus,allow the zygote to divide by mitosis to form a 2-cell embryo.3.Implant the embryos in a pseudopregnant foster mother and proceed offsprings.,-Over express protein 转基因动物模型 transgenic animal model.-基因敲除动物模型 gene knockout

10、animal model-基因敲入动物模型 gene knockin animal model-条件基因动物模型 conditional animal model,基因引入动物的方法,老年痴呆实验动物模型种类(续)Types of AD Animal Models,基因启动子种类-人Prion 基因启动子human PrP promoter(极微小的蛋白质颗粒,类似于病毒,但不含核酸,被认为是绵羊痒病和某些神经系统变性疾病的传染介质)-鼠Prion 基因启动子murine PrP promoter,-鼠CNP基因启动子murine CNP olygodendrocyte promoter-鼠胶

11、质原纤维酸性蛋白启动子 murine GFAP promoter-鼠钙调蛋白激酶IIa 启动子 Mouse CaMKIIa promotor(鼠产生的启动子,钙调蛋白激酶IIa 驱动基因表达在产后二周的前脑和海马部位),K.SantaCruz et al.,Science,309:476-481,2005,I.淀粉样蛋白连锁反应假说 The Amyloid Cascade HypothesisBy Dennis Selkoe,Harvard UniversityII.载脂蛋白对淀粉样蛋白的作用假说 Effects of ApoE on Amyloid-b Hypothesis By David

12、 M.Holtzman,Washington UniversityIII.蛋白质错误折叠和轴突转运障碍假说 Tau Related Axonal Transport Dysfunction Hypothesis By John Trojanowski,University of Pennsylvania2005 Update,老年痴呆发病机理研究AD Pathogenesis Studies,Dennis Selkoe,Nature.360(6405):672-4,Proc Natl Acad Sci U S A 91(25):11993-7.Cai XD et al.,Science,259

13、:514-6.Suzuki N et.al.,Science,264:1336-40,淀粉样蛋白连锁反应假说 The Amyloid Cascade Hypothesis,II.载脂蛋白对 A的作用假说 Effects of ApoE on Amyloid-b Hypothesis,II.载脂蛋白对 A的作用假说(续)Effects of ApoE on Amyloid-b Hypothesis,蛋白质错误折叠和轴突转运障碍假说 Protein Misfolding and Axonal Transport Dysfunction Hypothesis,Mechanisms Of Protei

14、n Misfolding And Brain Amyloidosis,Forman M,Trojanowski,JQ,Lee VM-Y.Nat Med,2004,a-synuclein,tau,vesicles,Tau aggregation/hyperphosphorylationDecreased MT bound tauMT depolymerization Impaired axonal transportAxonal degeneration&disconnection,Microtubules,Pathologicalaggregates,Deleterious Effects O

15、f Tau Amyloidosis,人类六个 tau 蛋白亚型的形成Human tau gene is alternatively spliced to produce six isoforms,Exons:0 1 2 3 4 4a 5 6 7 8 9 10 11 12 13 14,Alternatively spliced,GENE,TranscribedAlternatively splicedTranslated,微管结合重复序列,Tau基因的变异Mutations in the Tau Gene,EXON 1,EXON 9,EXON 11,EXON 12,EXON 13,K257T,I

16、260V,G272V,E342V,V337M,R406W,G389R,R5H/L,L266V,S320F,K369I,-AAUAAGAAGCUGGAUCUU-AAT-CCG,Intron 9,N279K,L284L,DN296N296HN296N,DK280,L315R,S352L,Q336R,EXON 10,P301S,P301L,S305N,S305S,INTRON 10SPLICESILENCER,INTRON 10SPLICEMODULATOR,Intron 10,+3,+11,+13,+12,+14,+16,EXON 10,The R406W mutation,located on

17、exon 13 of the tau gene,was identified in 3 distinct FTDP-17 kindreds.,精氨酸 色氨酸,正常 Tau蛋白的功能Normal Tau Protein,大量的低分子重量的微管相关旦白 An abundant low molecular weight microtubule-associated protein 分布在轴突 predominantly in axons促进并稳定微管聚合,维持正常的神经元轴突转运 Promotes microtubule(MT)polymerization,binds to MTs and stab

18、ilizes MTs 磷酸化降低与微管的结合能力 Phosphorylation negatively regulates the binding of tau to MTs,正常Tau旦白的功能:稳定微管并维持正常的神经元轴突转运Normal Tau Stabilizes MTs To Maintain Neuronal Transport,Tau病变引起神经元轴突转运障碍 While Tau Pathology Can Disrupt Neuronal Transport With Catastrophic Consequences Equivalent To A Train Wreck,

19、假说 Hypothesis,R406W Tau 转基因小鼠的研制Generation of T40hWT and T40R406W Tau Tg mice,精氨酸 色氨酸,Bin Zhang,Makoto Higuchi,Yasumasa Yoshiyama,Takeshi Ishihara,Mark S.Forman,Dan Martinez,Sonali Joyce,John Q.Trojanowski,and Virginia M.-Y.Lee,J Neurosci J.Neurosci.,24:4657,RW Tau 蛋白表达水平溶解性降低微管结合能力下降,方法:免疫电泳N-Tg:正常

20、非转基因小鼠hWT:正常 Tau 转基因小鼠RW:RW Tau 变异转基因小鼠,溶液强度RAB RIPA FA,细胞内Tau病变:类似神经元纤维缠结(NFT),脊髓新皮质小脑海马新皮质,RW Tg mice Develop Somatodendritic Tau Pathology Resembling NFTs,正常Tau 转基因小鼠,RW变异转基因小鼠,FTDP-17:Frontal temple dementia Parkinsonsm-17 Chromason,额颞叶痴呆巴金氏病-17染色体,方法:免疫组化,免疫电镜研究:RW Tau 蛋白的纤维形成,12m海马小脑新皮质脊髓,低倍 高

21、倍,RW:RW Tau 变异转基因小鼠,RW Tau 蛋白的分布改变:从轴突到细胞体,小脑,新皮质,Accumulation of Tau in the Neuronal Cell Soma,方法:免疫组化,正常 Tau 转基因小鼠,RW Tau 变异转基因小鼠,RW Tau 蛋白的分布改变:从轴突到细胞体Absence of Tau Staining in the Massy Fibers of Hippocampus in RW Mice,海马,方法:免疫组化hWT:正常 Tau 转基因小鼠RW:RW Tau 变异转基因小鼠,Tau 蛋白抗体 低分子量神经丝抗体,神经轴突转运的机制Mole

22、cular Machinery For Axonal Transport,轴突Axon,神经元胞体 Neuronal Cell body,顺行转运,逆行转运,Fast transport:1-4 mm/hour,Vesicles,TransmittersSlow Transport:0.2-0.4 mm/day,NFs,Tub,Actin,缓慢轴突转运研究Slow Axonal Transport,-35S-labeled methionine(甲硫氨酸)was microinjected into the L4-6 ventral horn using a stereotaxic appar

23、atus.-Groups of animals were sacrificed 7 days after microinjection for the analysis of slow axonal transport.The L4-5 ventral roots were removed and cut into consecutive 5 segments of 2 mm length from proximal to distal.,2 m6m,RW line 37,RW Tau 蛋白的轴突转运障碍,方法:免疫沉淀(IP),免疫电泳hWT:正常 Tau 转基因小鼠RW:RW Tau 变异

24、转基因小鼠,Tau 蛋白抗体 低分子量神经丝抗体,12 m6m,Slow Axonal Tau Transport is retarded in the early stage of RW Mice,RW line 60,RW Tau 蛋白的轴突转运障碍,RW line 37,方法:免疫沉淀(IP),免疫电泳hWT:正常 Tau 转基因小鼠RW:RW Tau 变异转基因小鼠,Tau 蛋旦白抗体 低分子量神经丝抗体,NFM17026,RW Tau 蛋白的轴突转运障碍,方法:免疫沉淀(IP),免疫电泳N-Tg:正常非转基因小鼠hWT:正常 Tau 转基因小鼠RW:RW Tau 变异转基因小鼠,中分

25、子量神经丝抗体,Tau 旦白抗体,脊髓腹根结扎,Since abnormal PHF tau proteins could not perform the normal function of binding to and stabilizing microtubules(MTs)in the polymerized state,could further effect MT functions,especially fast axonal transport.The hypothesis:MT stabilizing drugs such as PaxceedTM delivering to

26、 the CNS could have therapeutic benefit in brains with tauopathies,假说 Hypothesis,TaxolR(Paclitaxel,mw 854)-isolated in 1971 from plant,the pacific yew Taxus brevifonia-the first of a class of MT stabilizing drug which was approved for use in the treatment of breast,ovarian and lung cancers;-appears

27、to arrest cells in mitosis by stabilizing spindle MTs.-induce MT polymer mass in cell and“MT bundling”;-readily soluble in methanol,but limited soluble in water;PaxceedTM-A new MT Stabilizing anti-neoplastic agent by Angiotech Inc.;-In contrast to Taxol(Cremaphor formulation),PaxceedTM is a Micellar

28、 formulation that does not cause the inflammatory reactions;-Micellar paclitaxel is soluble in saline and once in the bloodstream,the micelles break down so that the paclitaxel can bind to serum albumin for bioavailability.,微管稳定药物MT Stabilizing Drugs,Over express the shortest tau isoform(T44)with mo

29、use PrP promotor;Tau inclusions begin to accumulate in spinal cord of 9 month old T44 tau Tg mice in association with the onset of motor impairments.,Neuron,Ishihara et al.,1999,T44 Tau Tg mice,NFTs accumulate with age in cortical neurons of T44 tau Tg mice.Pre-embedding immuno-EM shows tau immunore

30、active straight filaments in cortical NFTs of a 24 month old T44 tau Tg mouse.,AJP,Ishihara et al.,2001,T44 Tau Tg mice,-Retardation of fast axonal transport has been fund in these mice at 12 months old.,Neuron,Ishihara et al.,1999,快速轴突转运障碍,低剂量微管稳定药物改善轴突转运Fast Axonal Transport in the Ventral Root o

31、is Improved in the Low Dose of PaxceedTM Treated T44 Tg Mice,B:Ratio of proteins amount In each segment=Treated/ShamC:Percentage of TP Proteins in each segments=(protein in 1 segment/total proteins in 5 segments)x 100/100,Bin Zhang,Arpita Maiti,Sharon Shively,Fara Lakhani,Gaye McDonald-Jones,Jennife

32、r Bruce,Edward B.Lee,Sharon X.Xie,Sonali Joyce,Chi Li,Philip M.Toleikis,Virginia M.-Y.Lee,and John Q.Trojanowski PNAS 2005 102:227-231,中等剂量微管稳定药物改善轴突转运 Fast Axonal Transport in the Ventral Root is Improved in the Medium Dose of PaxceedTM Treated T44 Tg Mice,Medium,大剂量微管稳定药物减缓轴突转运 Fast Axonal Transpo

33、rt in the Ventral Root is Retarded in the High Dose of PaxceedTM Treated T44 Tg Mice,MTs in the VR Axons of the Tau Tg Mice Treated with PaxceedTM,The Numbers of MTs in the VR Axons Increase in the tau Tg Mice Treated with PaxceedTM,%,%,%,%,%,Bin Zhang,Arpita Maiti,Sharon Shively,Fara Lakhani,Gaye M

34、cDonald-Jones,Jennifer Bruce,Edward B.Lee,Sharon X.Xie,Sonali Joyce,Chi Li,Philip M.Toleikis,Virginia M.-Y.Lee,and John Q.Trojanowski PNAS 2005 102:227-231,Stable Detyrosinated Tubulin is Increased in the Ventral Root of T44 Tg Mice Treated with PaxceedTM,Summary,Dose dependant improvement of fast a

35、xonal transport in PrpT44 Tg mice by PaxceedTM treatment indicates that PaxceedTM treatment in the tau transgenic mice with existed retarded axonal transport is effective.MT stabilizing drugs,PaxceedTM could be a candidate for the further studies in treatment of AD and other neurodegenerative diseas

36、es with tauopathies.,Acknowledgement,Angiotech Pharmaceuticals Inc.Canada Arpita Maiti,Philip M.Toleikis,The University of PennsylvaniaThe Center for Neurodegenerative Disease ResearchMakoto Higuchi,MD.PhD.Yasumasa Yoshiyama,MD.PhD.Sona SundarrajMark S.Forman,MD.PhD.Lewis Z.Leng,Christine Kaminski,S

37、usan Leight,Virginia M.-Y.Lee MS.PhD John Q.Trojanowski MD.PhD,Acknowledgements,The Center for Neurodegenerative Disease ResearchMakoto Higuchi,MD.PhD.Yasumasa Yoshiyama,MD.PhD.Sona SundarrajMark S.Forman,MD.PhD.Lewis Z.Leng,Christine Kaminski,Susan Leight,Virginia M.-Y.Lee MS.PhD John Q.Trojanowski

38、 MD.PhDThe University of Pennsylvania USA,AD Animal Mmodel Comparison,II.载脂蛋白对 A的作用假说(续)Effects of ApoE on Amyloid-b Hypothesis,AD is a clinicopathological syndrome in which different gene defects can leaddirectly or indirectlyto altered APP expression or proteolytic processing or to changes in A st

39、ability or aggregation.These result in a chronic imbalance between A production and clearance.Gradual accumulation of aggregated A initiates a complex,multistep cascade that includes gliosis,inflammatory changes,neuritic/synaptic change,tangles and transmitter loss.By Dennis Selkoe.Harvard University,I.淀粉样蛋白连锁反应假说 The Amyloid Cascade Hypothesis,

展开阅读全文
相关资源
猜你喜欢
相关搜索

当前位置:首页 > 建筑/施工/环境 > 农业报告


备案号:宁ICP备20000045号-2

经营许可证:宁B2-20210002

宁公网安备 64010402000987号